These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 29097483)

  • 21. Regulators of hepcidin expression.
    Roth MP; Meynard D; Coppin H
    Vitam Horm; 2019; 110():101-129. PubMed ID: 30798807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin A deficiency modulates iron metabolism via ineffective erythropoiesis.
    da Cunha MS; Siqueira EM; Trindade LS; Arruda SF
    J Nutr Biochem; 2014 Oct; 25(10):1035-44. PubMed ID: 24998947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developmental changes in iron metabolism and erythropoiesis in mice with human gain-of-function erythropoietin receptor.
    Kralova B; Sochorcova L; Song J; Jahoda O; Hlusickova Kapralova K; Prchal JT; Divoky V; Horvathova M
    Am J Hematol; 2022 Oct; 97(10):1286-1299. PubMed ID: 35815815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of hepcidin expression at high altitude.
    Talbot NP; Lakhal S; Smith TG; Privat C; Nickol AH; Rivera-Ch M; León-Velarde F; Dorrington KL; Mole DR; Robbins PA
    Blood; 2012 Jan; 119(3):857-60. PubMed ID: 22130801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating iron levels influence the regulation of hepcidin following stimulated erythropoiesis.
    Mirciov CSG; Wilkins SJ; Hung GCC; Helman SL; Anderson GJ; Frazer DM
    Haematologica; 2018 Oct; 103(10):1616-1626. PubMed ID: 29903760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A critical role for murine transferrin receptor 2 in erythropoiesis during iron restriction.
    Wallace DF; Secondes ES; Rishi G; Ostini L; McDonald CJ; Lane SW; Vu T; Hooper JD; Velasco G; Ramsay AJ; Lopez-Otin C; Subramaniam VN
    Br J Haematol; 2015 Mar; 168(6):891-901. PubMed ID: 25403101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepcidin.
    Ganz T
    Rinsho Ketsueki; 2016; 57(10):1913-1917. PubMed ID: 27725588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of iron metabolism and erythropoiesis in erythrocyte membrane defects and thalassemia traits.
    Sulovska L; Holub D; Zidova Z; Divoka M; Hajduch M; Mihal V; Vrbkova J; Horvathova M; Pospisilova D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Jun; 160(2):231-7. PubMed ID: 26592557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepcidin in chronic kidney disease anemia.
    Santos-Silva A; Ribeiro S; Reis F; Belo L
    Vitam Horm; 2019; 110():243-264. PubMed ID: 30798815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of GlyT1 inhibition on erythropoiesis and iron homeostasis in rats.
    Winter M; Funk J; Körner A; Alberati D; Christen F; Schmitt G; Altmann B; Pospischil A; Singer T
    Exp Hematol; 2016 Oct; 44(10):964-974.e4. PubMed ID: 27403535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver iron modulates hepcidin expression during chronically elevated erythropoiesis in mice.
    Díaz V; Gammella E; Recalcati S; Santambrogio P; Naldi AM; Vogel J; Gassmann M; Cairo G
    Hepatology; 2013 Dec; 58(6):2122-32. PubMed ID: 23744538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unraveling mechanisms regulating systemic iron homeostasis.
    Finberg KE
    Hematology Am Soc Hematol Educ Program; 2011; 2011():532-7. PubMed ID: 22160085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythroferrone structure, function, and physiology: Iron homeostasis and beyond.
    Srole DN; Ganz T
    J Cell Physiol; 2021 Jul; 236(7):4888-4901. PubMed ID: 33372284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project.
    Piperno A; Galimberti S; Mariani R; Pelucchi S; Ravasi G; Lombardi C; Bilo G; Revera M; Giuliano A; Faini A; Mainini V; Westerman M; Ganz T; Valsecchi MG; Mancia G; Parati G;
    Blood; 2011 Mar; 117(10):2953-9. PubMed ID: 21149632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study.
    Kakimoto-Shino M; Toya Y; Kuji T; Fujikawa T; Umemura S
    Ther Apher Dial; 2014 Oct; 18(5):421-6. PubMed ID: 24456328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ironing out Ferroportin.
    Drakesmith H; Nemeth E; Ganz T
    Cell Metab; 2015 Nov; 22(5):777-87. PubMed ID: 26437604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypobaric hypoxia regulates iron metabolism in rats.
    Li Y; Zhou Y; Zhang D; Wu WY; Kang X; Wu Q; Wang P; Liu X; Gao G; Zhou Y; Wang G; Chang YZ
    J Cell Biochem; 2019 Aug; 120(8):14076-14087. PubMed ID: 30968973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.
    Ginzburg Y; Rivella S
    Blood; 2011 Oct; 118(16):4321-30. PubMed ID: 21768301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron homeostasis and erythropoiesis.
    Wrighting DM; Andrews NC
    Curr Top Dev Biol; 2008; 82():141-67. PubMed ID: 18282520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.
    Reichert CO; da Cunha J; Levy D; Maselli LMF; Bydlowski SP; Spada C
    Acta Haematol; 2017; 137(4):220-236. PubMed ID: 28514781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.